HIF1α is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosis
Yoshiteru Miyauchi(Mitsubishi Chemical (Japan)), Takeshi Miyamoto(Kumamoto Health Science University), Shigeaki Kato(Fukushima Medical University), Kana Miyamoto(Kumamoto University), Hiroya Kanagawa(Keio University), Hideo Morioka, Eri Katsuyama(Okayama University of Science), Tami Kobayashi(Keio University), Atsuhiro Fujie(Keio University), Tomoaki Mori(Harvard University), Morio Matsumoto(Keio University Hospital), Toshimi Tando, Pierre Chambon(Centre National de la Recherche Scientifique), Hao Wu, Yoshiaki Toyama(Keio University), Randall S. Johnson(Athena Group (United States)), Yuiko Sato(Keio University), Shigeyuki Yoshida(Keio University)
Cited by 181
Related Papers
Biology of HIF-1α
|Cell Death and Differentiation|2008|923
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
|Cell Metabolism|2006|771
Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors
|The Journal of Experimental Medicine|1999|694
Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)
|Journal of Clinical Investigation|2007|633